Drug development for stroke: importance of protecting cerebral white matter
- 1 June 1999
- journal article
- review article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 375 (1-3) , 41-50
- https://doi.org/10.1016/s0014-2999(99)00280-0
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Delayed oligodendrocyte degeneration induced by brief exposure to hydrogen peroxideJournal of Neuroscience Research, 1999
- Six-Hour Window of Opportunity for Calpain Inhibition in Focal Cerebral Ischemia in RatsStroke, 1998
- Endothelin-B Receptors in Cerebral Resistance Arterioles and their Functional Significance after Focal Cerebral Ischemia in CatsJournal of Cerebral Blood Flow & Metabolism, 1997
- Cerebral White Matter Is Highly Vulnerable to IschemiaStroke, 1996
- Increased tau immunoreactivity in oligodendrocytes following human stroke and head injuryNeuroscience Letters, 1996
- Calpain inhibitor AK295 protects neurons from focal brain ischemia. Effects of postocclusion intra-arterial administration.Stroke, 1994
- Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia.Stroke, 1994
- Role for gamma-aminobutyric acid in selective vulnerability in gerbils.Stroke, 1989
- Reversible middle cerebral artery occlusion without craniectomy in rats.Stroke, 1989
- Cerebrovascular permeability following MCA occlusion in the ratJournal of Neurosurgery, 1982